Dr.Lahan'S Laboratories Private Limited
Conducts research and development services in pharmacy.
1989 | Secunderabad, Telangana (India) | Active
Dr.Lahan'S Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.40 M
- Company Age 36 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -88.72%
- Profit Growth -92.31%
- Ebitda 53.23%
- Net Worth 4.62%
- Total Assets -9.64%
About Dr.Lahan'S Laboratories
Dr.Lahan's Laboratories Private Limited (DLPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 January 1989 and has a history of 36 years and one month. Its registered office is in Secunderabad, Telangana.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Karunamay Lahiri and Swapna Lahiri serve as directors at the Company.
Company Details
- Location Secunderabad, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG1989PTC009460
- Company No.
009460
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Dr.Lahan'S Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karunamay Lahiri  | Director | 04-Jan-1989 | Current |
| Swapna Lahiri | Director | 04-Jan-1989 | Current |
Financial Performance of Dr.Lahan'S Laboratories.
Dr.Lahan'S Laboratories Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 88.72% decrease. The company also saw a substantial fall in profitability, with a 92.31% decrease in profit. The company's net worth moved up by a moderate rise of 4.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Lahan'S Laboratories?
In 2020, Dr.Lahan'S Laboratories had a promoter holding of 77.44% and a public holding of 22.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr.Lahan'S Laboratories?
Unlock and access historical data on people associated with Dr.Lahan'S Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Lahan'S Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Lahan'S Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.